1-Alpha-hydroxycholecalciferol in the treatment of hypocalcaemic psychosis (Q40026263)

16 September 2017

1-Alpha-hydroxycholecalciferol in the treatment of hypocalcaemic psychosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A186220

25 May 2022

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

25 May 2022

author name string

J. M. Gertner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A186220

25 May 2022

A. B. Hodsman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A186220

25 May 2022

J. N. Neuberger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A186220

25 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=186220

25 May 2022

publication date

1 September 1976

1 reference

full work available at URL

16 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1976.tb01983.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1976.tb01983.x/fullpdf

25 May 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

25 May 2022

published in

Clinical Endocrinology

1 reference

16 September 2017

5

1 reference

16 September 2017

5

1 reference

16 September 2017

539-543

1 reference

1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance

16 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1976.TB01983.X

Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1976.TB01983.X

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1976.TB01983.X

I alpha-hydroxycholecalciferol: a treatment of renal bone disease

21 January 2018

2

12

Catto G. R. D.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency

25 May 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

1α-Hydroxycholecalciferol. Long-Term Treatment of Patients with Uraemic Osteodystrophy

25 May 2022

8

16

359

Pors Nielsen S.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol

25 May 2022

9

51

2502

Rasmussen H.

1972

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism

25 May 2022

10

14

Russell R. G.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB01983.X

25 May 2022

Identifiers

1 reference

16 September 2017

1 reference